Article

NeurologyLive® Top Expert Interviews: January 2022

Author(s):

Expert clinicians offer their insight on conducting trials in pediatric migraine, the pipeline of Alzheimer therapies, disorders of consciousness and COVID-19, and more.

The NeurologyLive® team has been as busy as always bringing you the latest clinical news and research updates in neurology over the last month, including conducting several interviews with experts across a number of different and varying topics.

Among these included conversations about the challenges in conducting clinical trials in migraine with Christina Szperka, MD, MSCE; the use of MR fingerprinting in epilepsy care with Irene Wang, PhD; the current understanding of disorders of consciousness and COVID-19 with David Fischer, MD; the development of the SAGE test for early dementia detection with Douglas Scharre, MD; addressing disparities in the US following COVID-19 with Mitzi Joi Williams, MD; and the current monoclonal antibodies in development for Alzheimer disease with Anton Porsteinsson, MD.

Click through the slides to see and read more from each expert’s exclusive conversation with NeurologyLive® in January 2022.

To hear more insight from experts in the clinical care of patients and leading researchers in neurology, check out more of NeurologyLive®'s videos.

REFERENCES
1. Szperka CL, Ailani J, Barmherzig R, et al. Migraine care in the era of COVID-19: Clinical pearls and plea to insurers. Headache. 2020;60(5):833-842. doi:10.1111/head.13810
2. Choi JY, Su T, Hu S, et al. MR Fingerprinting radiomics for characterization of focal cortical dysaplasia. Presented at AES Annual Meeting; December 3-7, 2021. Poster 3.235
3. Fischer D, Snider SB, Barra ME, et al. Disorders of consciousness associated with COVID-19: A prospective, multimodal study of recovery and brain connectivity. Neurology. Published online December 3, 2021. doi:10.1212/WNL.0000000000013067
4. Scharre DW, Chang S, Nagaraja HN, Wheeler NC, Kataki M. Self-Administered Gerocognitive Examination: longitudinal cohort testing for the early detection of dementia conversion. Alzheimers Res Ther. 2021;13(1):192. doi:10.1186/s13195-021-00930-4

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Videos
Molly Abbott, BM BCh
Laren Becker, MD, PhD
David Shprecher, DO, MSci, FAAN
Pamela Zeilman, NP
© 2025 MJH Life Sciences

All rights reserved.